Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record now states 'No longer looking for participants', indicating recruitment is closed for this trial. The revision line shows 'Revision: v3.6.0' replacing the previous 'Revision: v3.5.5', signaling an updated version of the study record.SummaryDifference0.3%

- Check18 days agoChange DetectedA new site revision entry (v3.5.5) is added to the record history, replacing the previous revision (v3.5.4) and signaling an updated deployment of the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check40 days agoChange DetectedThe page footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a newer software version has been applied to the page.SummaryDifference0.1%

- Check61 days agoChange DetectedA minor update to the ClinicalTrials.gov interface version is reflected in the page footer, moving from revision v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 deleted.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.